T issue homeostasis relies on the activity of a small population of adult stem cells that have the capacity to generate short-lived differentiated cells while maintaining their identity through self-renewal 1 . Recently, in vivo clonogenic studies have revealed that in the mature T cell compartment, adult stem cells are confined to the CD62L + memory T cell pool (which comprises stem cell-like memory T cells and central memory T cells (T CM cells)) 2-4 . There has been growing interest in the identification of the molecular, epigenetic and metabolic factors orchestrating the formation and maintenance of stem cell-like T cells, since these cells are known to be critical for the long-term efficacy of T cell-based immunotherapy and vaccines 5 .
pmel-1 Myb fl/fl T cells isolated from littermates (Fig. 1b) were adoptively transferred into wild-type mice infected with a recombinant strain of vaccinia virus encoding gp100 (gp100-VV), and antigenspecific CD8 + T cell expansion and persistence were monitored over time (Fig. 1c ). We found that in the absence of Myb, CD8 + T cells showed a minor defect in splenic accumulation during the acute phase of the immune response ( Fig. 1d,e ). However, following the peak of expansion, the number of c-Myb-deficient T cells contracted more sharply than did that of wild-type cells, resulting in fewer memory cells 1 month after transfer. A steep decline in c-Myb-deficient CD8 + T cell frequency during the contraction phase was similarly observed in lymph nodes ( Supplementary Fig. 1a,b ) and lungs ( Supplementary Fig. 1c,d) , underscoring the importance of c-Myb in cell maintenance.
To determine whether the reduced accumulation of c-Mybdeficient CD8 + T cells was due to defects in proliferation, we measured 5-bromo-2′-deoxyuridine (BrdU) uptake in transferred cells responding to gp100-VV infection. Early on, most antigen-specific cells were vigorously proliferating, independently of the presence of c-Myb ( Supplementary Fig. 2a,b) . Surprisingly, a substantial fraction of c-Myb-deficient T cells continued to take up BrdU, while most wild-type CD8 + T cells stopped actively dividing at the peak of expansion ( Supplementary Fig. 2a,b) . Thus, the reduced accumulation of Myb ∆/∆ T cells was not caused by defective proliferation. Therefore, we determined whether the differences in cell numbers were linked to a survival disadvantage. Measuring apoptosis with annexin V revealed that in the absence of Myb, CD8 + T cells underwent massive apoptosis in the initial phase of the immune response ( Supplementary Fig. 2c,d ). This tendency, although not statistically significant, was also observed at the peak of the response ( Supplementary Fig. 2c,d) . These data emphasize the pivotal role of c-Myb in mature T cell survival, consistent with known findings in thymocytes 18, 24 .
Increased turnover and apoptosis of pmel-1 Myb ∆/∆ T cells might result from alteration of their differentiation program. We therefore evaluated the frequency of memory precursors and terminally differentiated effector T cells (T TE cells) by measuring the expression of KLRG1 and CD62L on transferred pmel-1 T cells 5 d after gp100-VV infection. The deletion of Myb resulted in a fourfold increase in splenic KLRG1 + CD62L − T TE cells and a dramatic loss of KLRG1 − CD62L + memory precursors, compared to controls ( Fig. 1f,g) . Similarly, there was a marked accumulation of T TE cells and depletion of CD62L + cells among c-Myb-deficient T cells in the lymph nodes and lungs ( Supplementary Fig. 3 ). These findings were also observed when physiological numbers of antigen-specific T cells 25 were transferred (data not shown). Although we did not measure major differences in perforin expression (data not shown), Myb-deficient T cells displayed a larger amount of granzyme B (Fig. 1h ) and enhanced killing capacity in vitro ( Fig. 1i ), in further support of the observation that c-Myb inhibits terminal effector differentiation. As T cells progressively differentiate into T TE cells, they first lose the capacity to produce interleukin 2 (IL-2) and then the capacity to produce tumor necrosis factor (TNF) before ultimately becoming monofunctional interferon-γ (IFN-γ) producers 26 . Myb ∆/∆ T cells exhibited poor polyfunctionality, as evidenced by the reduced frequency of IL-2 + TNF + IFN-γ + cells (Fig. 1j,k) . Notably, nearly half of the cytokine-producing Myb ∆/∆ T cells were single IFN-γ producers, functionally consistent with our observation that CD8 + T cells were driven toward terminal differentiation in the absence of c-Myb. T cell differentiation is also intrinsically linked to changes in metabolism. For instance, effector T cells display reduced oxidative metabolism and mitochondrial spare respiratory capacity (SRC) compared with that of memory cells 27 . Accordingly, Myb ∆/∆ T cells displayed a lower basal oxygen-consumption rate (OCR) and a striking reduction in SRC compared with that of wildtype cells ( Fig. 1l-n ). These differences in cellular metabolism were in part independent of a skewed T TE cell frequency, as manifested by a small but significant reduction of mitochondrial fatty acid oxidation in Myb-deficient T cells after phenotypic normalization ( Supplementary Fig. 4 ). Taken together, phenotypic, functional and metabolic analyses concordantly demonstrate that c-Myb restrains CD8 + T cell terminal differentiation.
Consistent with a reduction in memory precursors generated in the acute phase of the immune response, we observed both decreased quantities of total memory cells ( Fig. 1d,e ) and decreased frequencies of stem cell-like T CM cells in Myb-deficient T cells 30 d after transfer (Fig. 1o,p) . The hallmark function of memory cells is the ability to mount a robust response after secondary infection. To determine whether Myb-deficient memory T cells were functionally competent, we transferred equal numbers of Myb ∆/∆ or wild-type memory T cells into syngeneic hosts and measured their expansion 5 d after infection with gp100-encoding adenovirus type 2 (gp100-Adv). Strikingly, we observed a dramatic impairment in the ability of Myb ∆/∆ T cells to mount secondary immune responses ( Fig. 1q,r) . Together, these results demonstrate that c-Myb is essential for the generation of long-lived and functional stem cell-like T CM cells.
c-Myb is indispensable for CD8 + T cell stemness.
Persistence is a hallmark of stemness 4 . To determine the role of c-Myb in the persistence of CD8 + T cells, we first evaluated the long-term maintenance of memory cells generated in the absence of Myb by measuring the frequency and number of adoptively transferred pmel-1 of B16-hgp100 melanoma after co-culture with pmel-1 Myb +/+ or pmel-1 Myb ∆/∆ CD8 + T cells (n = 6 technical replicates). j,k, Intracellular cytokine staining (j) and combinatorial cytokine production (k) by pmel-1 T cells 5 d after transfer as in d,e. l, OCR of pmel-1 Myb +/+ and pmel-1 Myb ∆/∆ CD8 + T cells activated in vitro with antibodies to CD3 and CD28 in the presence of IL-2. Data shown were obtained under basal conditions and in response to the indicated molecules (n = 5 technical replicates). FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; Ant, antimycin; Rot, rotenone. m,n, Basal OCR (m) and SRC (n) of pmel-1 T cells generated as in l (n = 15 technical replicates; five replicates × three time points). o, Flow cytometry of pmel-1 T cells in the lymph nodes 30 d after transfer as in d,e. p, Percentage of KLRG1 − CD62L + pmel-1 T cells in the lymph nodes 30 d after transfer as in d,e. q,r, Flow cytometry of splenocytes (q) and numbers of splenic pmel-1 T cells (r) 5 d after the transfer of 5 × 10 4 pmel-1 Ly5.2 + Myb fl/fl or pmel-1 Ly5.2 + Myb ∆/∆ primary memory CD8 + T cells, followed by secondary infection with gp100-adV (n = 3). Data are representative of at least two independent experiments. Data are shown after gating on live CD8 + cells (b,d), CD8 + Thy1.1 + cells (f,h,j,o) or CD8 + Ly5.2 + cells (q). Data in e-j,l-n,p,r are shown as mean ± s.e.m.; each symbol represents an individual mouse (g,h,p,r) or technical replicate (i,m,n). NS, not significant; *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001, (unpaired two-tailed Student's t-test).
Myb ∆/∆ or pmel-1 Myb fl/fl T cells 90 d after infection with gp100-VV ( Fig. 2a ). Notably, we found a striking reduction in the number of total and stem cell-like T CM cells in the spleen of mice that received Myb-deficient cells, compared with that of controls ( Fig. 2b,c) . The reduction in the number of Myb ∆/∆ T cells was not due to a skewed distribution, because Myb ∆/∆ T cells were similarly decreased in lungs and lymph nodes ( Supplementary Fig. 5a-d ). Compared to results obtained at day 30 ( Fig. 1d,e ), we observed wider differences in cell frequencies and numbers, indicating that memory cells undergo progressive attrition in the absence of c-Myb.
Second, we determined the ability of Myb-deficient T cells to generate secondary memory cells. We transferred equal numbers of memory cells generated 45 d after primary infection into secondary recipients and assessed the frequency and number of pmel-1 Myb ∆/∆ or pmel-1 Myb fl/fl T cells 1 month after infection with gp100-Adv ( Fig. 2d ). Myb-deficient T cells exhibited a reduced capacity to form secondary memory cells in all organs evaluated ( Fig. 2e,f and Supplementary Fig. 5e -h). More importantly, the generation of stem cell-like T CM cells was markedly impaired, as evidenced by a 98.8% reduction in splenic CD62L + T cell numbers ( Fig. 2g,h ).
Finally, we tested the impact of Myb deficiency on stem cell-like T CM cell self-renewal. We labeled flow cytometry-sorted CD62L + memory CD8 + T cells with the division-tracking dye CFSE (carboxyfluorescein succinimidyl ester) and transferred them into sublethally irradiated mice ( Fig. 2i ). 4 weeks later, we measured CFSE dilution and maintenance of a stem cell-like phenotype under homeostatic proliferation. Wild-type T cells displayed robust selfrenewal, as shown by the retention of CD62L expression on CFSEdiluted cells (Fig. 2j ). Myb-deficient T cells were unable to persist ( Fig. 2j ). Of note, only half of the few surviving cells were able to maintain their stem cell-like phenotype (Fig. 2j ). Taken together, these experiments indicate that c-Myb is an essential regulator of CD8 + T cell stemness. c-Myb enhances CD8 + T cell stemness by regulating Tcf7, Bcl2 and Zeb2 expression. To understand the mechanisms by which c-Myb regulates CD8 + T cell differentiation, we performed RNA-seq of pmel-1 Myb +/+ and pmel-1 Myb ∆/∆ T cells harvested 5 d after adoptive transfer into mice infected with gp100-VV. To minimize skewing in gene expression due to differences in T cell subset distribution among Myb +/+ and Myb ∆/∆ T cells, we analyzed KLRG1 − CD62L − cells sorted with a purity of >99% by flow cytometry ( Supplementary  Fig. 6a ). Even after subset normalization, Myb ∆/∆ T cells were enriched with genes known to be highly expressed in effector cells, whereas Myb +/+ T cells contained a larger proportion of transcripts associated with memory precursors ( Fig. 3a , Supplementary Fig.  6b ,c and Supplementary Table 1 ). To elucidate downstream effectors of c-Myb, we filtered the dataset by selecting genes reported to be directly regulated (activated or repressed) by c-Myb in promyelocytes 28 . Bcl2, a well-established target of c-Myb 29, 30 , was downregulated in Myb ∆/∆ T cells ( Fig. 3a and Supplementary Table 1 ), in keeping with the survival defect observed in pmel-1 Myb ∆/∆ T cells ( Supplementary Fig 2c,d ). Pathway analysis further revealed induction of transcriptional networks promoting cell death among Myb ∆/∆ T cells (Supplementary Table 2 ). Two genes encoding crucial transcription factors that regulate CD8 + T cell differentiation, Tcf7 and Zeb2 13,14,31,32, were differentially expressed in Myb ∆/∆ and Myb +/+ cells ( Fig. 3a and Supplementary Table 1 ). The gene encoding Tcf1 (Tcf7), which enhances the formation and maintenance of memory T cells, was downregulated in Myb ∆/∆ T cells. Conversely, Zeb2, which encodes a driver of CD8 + T cell terminal differentiation 31, 32 , was upregulated in the absence of Myb (Fig. 3a ). Gene-set-enrichment analysis (GSEA) corroborated these findings by revealing that Myb ∆/∆ T cells were enriched with genes upregulated in CD8 + T cells lacking WNT-reporter activity 33 (Fig. 3b , left) and genes upregulated in Zeb2-sufficient CD8 + T cells 32 (Fig. 3b , right).
To further elucidate the relationship of Myb expression with that of Bcl2, Tcf7 and Zeb2 during CD8 + T cell differentiation, we quantified the transcripts of these genes in naïve, CD62L + and CD62L − pmel-1 T cells generated in response to gp100-VV. As Myb expression declined with differentiation from naïve T cells into CD62L − cells, Bcl2 and Tcf7 transcripts decreased ( Fig. 3c,d ),
whereas Zeb2 expression was inversely related to Myb expression ( Fig. 3e ). We next sought to evaluate how the genetic manipulation of Myb would affect Bcl2, Tcf7 and Zeb2 expression. To this end, we adoptively transferred into gp100-VV-infected mice pmel-1 Myb +/+ , pmel-1 Myb ∆/∆ and pmel-1 T cells transduced with Myb-Thy1.1 or Thy1.1 alone. 5 d later, we analyzed Bcl2, Tcf7 and Zeb2 expression in the transferred T cells. Reinforcing our RNA-seq results, Myb deletion resulted in a significant reduction in the expression of Bcl2 and Tcf7 (Fig. 3f ,g) while dramatically increasing Zeb2 expression ( Fig. 3h ). By contrast, Myb overexpression enhanced the expression of both Bcl2 and Tcf7 (Fig. 3f ,g) and suppressed Zeb2 expression ( Fig. 3h ). Similar findings were obtained by measurement of Bcl2 and Tcf1 proteins ( Fig. 3i,j) . The lack of working mouse Zeb2specific antibodies prevented assessment of the impact of c-Myb on Zeb2 protein expression. Transcriptional regulation of Tcf7 by c-Myb was confirmed by a reporter assay using CD8 + T cells from Tcf7 GFP/+ mice (data not shown). Bcl2 is regulated by c-Myb 30 . Whether c-Myb directly binds to and regulates the expression of Tcf7 and Zeb2 in CD8 + T cells merited further analysis. We performed chromatin immunoprecipitation (ChIP) followed by qPCR in pmel-1 Myb +/+ and Myb ∆/∆ T cells and found specific enrichment of Tcf7 enhancer and Zeb2 promoter regions with c-Myb immunoprecipitation in wild-type cells but not in Myb ∆/∆ T cells ( Fig. 3k ). Taken together, these findings place c-Myb as a transcriptional activator of Bcl2 and Tcf7 and as a transcriptional repressor of Zeb2 in CD8 + T cells.
We next sought to determine whether the tendency for Myb ∆/∆ CD8 + T cells to undergo terminal differentiation depends on insufficient levels of Tcf7 and unrestrained expression of Zeb2. To this end, we adoptively transferred pmel-1 Myb ∆/∆ T cells and pmel-1 Myb ∆/∆ Zeb2 +/∆ T cells transduced with either Tcf7-GFP or GFP alone in gp100-VV infected mice and evaluated the formation of KLRG1 + CD62L − T TE cells in comparison with that of pmel-1 Myb fl/fl cells transduced with the GFP control. Testing of complete Zeb2 deficiency on pmel-1 Myb ∆/∆ T cells was not possible. The Zeb2 locus is located on chromosome 2, just 12 centimorgans from the insertion site of the pmel-1 Tcra and Tcrb transgenes 22 ; therefore, there is a slim probability of obtaining a Zeb2 fl/fl with pmel-1 background. Consistent with our results using naïve CD8 + T cells ( Fig. 1f,g) , in vitro-activated pmel-1 cells engineered to express GFP alone generated higher frequencies of T TE cells in the absence of Myb (Fig. 3l,m) . Individually, overexpression of Tcf7 or Zeb2 haploinsufficiency significantly reduced the frequency of T TE cells among pmel-1 Myb ∆/∆ GFP T cells, although Zeb2 depletion had a more pronounced effect ( Fig. 3l,m) . The combination of both genetic approaches completely rescued the skewed differentiation pattern of pmel-1 Myb ∆/∆ GFP T cells ( Fig. 3l,m) . Despite correcting the differentiation program, these genetic maneuvers did not rescue the survival defects of pmel-1 Myb ∆/∆ T cells, implicating Bcl2 and other downstream factors behind the pro-survival function of c-Myb (Fig. 3n,o) . Thus, c-Myb promotes CD8 + T cell stemness both by inducing promemory and survival programs via Tcf7 and Bcl2 and by restraining effector differentiation through suppression of Zeb2.
Distinct functions of c-Myb domains in the regulation of CD8 + T cell differentiation and survival. To further characterize the molecular mechanisms by which c-Myb regulates CD8 + T cell differentiation and survival, we generated a complement of c-Myb mutants and tested their ability to rescue the phenotype of pmel-1 Myb ∆/∆ T cells. We compared the activity of full-length c-Myb with that of three different c-Myb mutants 34 : truncated c-Myb lacking the NRD (the 'Myb (1-330)' construct); a c-Myb mutant with a nonfunctional TAD (insertion of glycine and proline after the amino acid residue at position 304 (the 'Myb 304GP' construct); and truncated c-Myb comprising the DNA-binding domain only (the 'Myb pBind' construct) (Fig. 4a ). These were cloned into an MSGV-Thy1.1 retroviral vector to allow the sorting and tracking of transduced pmel-1 T cells after adoptive transfer into wild-type mice infected with gp100-VV (Fig. 4a ). With the exception of the Myb pBind construct, which resulted in higher levels of Myb transcription, all constructs induced comparable levels of Myb transcripts (data not shown). As we previously observed, pmel-1 Myb ∆/∆ Thy1.1 + T cells generated higher frequencies of T TE cells at the peak of the immune response than did pmel-1 Myb +/+ Thy1.1 + T cells (Fig. 4b,c ). As expected, fulllength c-Myb significantly reduced the percentage of T TE cells (Fig. 4b,c) . Myb (1-330) not only abolished the generation of T TE cells but also dramatically increased the frequency of CD62L + memory precursors (Fig. 4b,c) , confirming the NRD's self-regulation of Myb in CD8 + T cells. Conversely, Myb pBind and Myb 304GP failed to rescue the phenotype of pmel-1 Myb ∆/∆ T cells (Fig. 4b,c Myb (Fig. 4d,e ). On the other hand, Myb pBind, which did not rescue the phenotype of pmel-1 Myb ∆/∆ T cells, did not lower Zeb2 expression and failed to induce Tcf7 (Fig. 4d,e ). Myb 304GP, which was inefficient in inhibiting CD8 + T cell differentiation, did retain high levels of Zeb2 and induce Tcf7, albeit to a lesser extent than did full-length c-Myb (Fig. 4d,e ). This emphasizes the more prominent role of Zeb2 over that of Tcf1 in the regulation of T TE cells. Thus, the c-Myb TAD restrains CD8 + T cell differentiation by promoting Tcf7 expression but mostly by suppressing Zeb2 transcription. Despite being unable to correct CD8 + T cell differentiation, Myb 304GP fully rescued the frequency and total number of pmel-1 Myb ∆/∆ T cells (Fig. 4f,g) . Evidently, the prosurvival effects of c-Myb are independent of its TAD activity and its regulation of Tcf7 and Zeb2 (Fig. 3n,o) . Further substantiating this conclusion is the finding that Myb (1-330), which markedly inhibited CD8 + T cell differentiation, induced Tcf7 and suppressed Zeb2 expression but did not increase pmel-1 T cell frequency or total number to the levels produced by Myb +/+ T cells (Fig. 4f,g) .
Combined with the results from Myb pBind complementation (Fig. 4f,g) , the pro-survival activity of c-Myb is linked mainly to the integrity of its C-terminal domain. In summary, the c-Myb TAD is critical for regulating CD8 + T cell differentiation, but it is the NRD that is essential for maintaining cell survival.
Enforced Myb expression enhances CD8 + T cell stemness and polyfunctionality.
Having demonstrated the pivotal role of c-Myb in the regulation of CD8 + T cell stemness, we next sought to determine whether the generation of stem cell-like T CM cells could be enhanced by enforcing Myb expression. We transduced pmel-1 Ly5.1 + T cells with Myb-Thy1.1 and pmel-1 Ly5.2 + T cells with Thy1.1 alone, mixed them at a 1:1 ratio and cotransferred them into wild-type mice infected with gp100-VV ( Fig. 5a ). Overexpression of c-Myb enhanced the expansion of splenic pmel-1 T cells, which accumulated at fourfold the rate of control cells at the peak of the immune response (Fig. 5b,c) . Likewise, we observed increased expansion of Myb-overexpressing pmel-1 T cells in lungs and lymph nodes, although the accumulation was more pronounced in the latter ( Supplementary Fig.  7a-d) . Enforcing Myb expression did not increase the number of pmel-1 T cells in the spleen and lungs 30 d after transfer (Fig. 5b,c and Supplementary Fig. 7a,b) , indicating that c-Myb overexpression alone is insufficient to cause unrestrained T cell expansion or transformation 20 . We observed, however, a dramatic increase in pmel-1 T cells (~50-fold) in the lymph nodes ( Supplementary  Fig. 7c,d) , which prompted us to investigate whether the increased accumulation of Myb-overexpressing T cells in the lymph nodes was due to the preferential formation of stem cell-like T CM cells, which preferentially home to lymphoid tissues. Consistent with our findings using c-Myb-deficient T cells, we found that overexpression of c-Myb promoted the generation of stem cell-like T CM cells while restraining terminal effector differentiation (Fig. 5d,e and Supplementary Fig. 7e,f) . These results were further strengthened by functional studies, which revealed that Myb-overexpressing cells displayed enhanced polyfunctionality and a sustained capacity to produce IL-2 ( Fig. 5f-h) . Taken together, these results demonstrate that increasing Myb levels in CD8 + T cells is an effective strategy for generating polyfunctional stem cell-like T CM cells.
Enforced expression of Myb enhances CD8 + T cell recall responses and antitumor immunity.
The hallmark of memory cells is their capacity to rapidly proliferate and differentiate into a massive number of effector cells after secondary infection. To determine whether enhanced generation of stem cell-like T CM cells resulting from c-Myb overexpression would promote stronger recall responses, we re-challenged mice that were initially infected with gp100-VV with gp100-adV (Fig. 6a) . Strikingly, the accumulation of splenic Myb-overexpressing T cells at the peak of the secondary immune response was 10-fold higher in frequency and number than that of control cells (Fig. 6b,c) . Repeated antigen stimulations are known to drive CD8 + T cells toward terminal differentiation 35, 36 . To determine whether terminal differentiation could be restrained by overexpression of c-Myb, we measured T TE cells after secondary infection with gp100-adV. Remarkably, c-Myb overexpression not only dramatically reduced the frequencies of T TE cells in both peripheral and lymphoid tissues ( Fig. 6d -i) but also maintained a higher fraction of stem cell-like T CM cells. Moreover, intracellular cytokine staining analyses showed a marked reduction in terminally differentiated, monofunctional IFN-γ producers in the Myb-overexpression group (Fig. 6j-l) . It is well established that the dose of adoptively transferred tumor-specific CD8 + T cells correlates with the magnitude of tumor regression 37 . Generating large numbers of tumor-reactive T cells in vitro can be counterproductive, however, because as cells expand they progressively differentiate into T TE cells with limited therapeutic fitness 35 . We sought to determine whether overexpression of c-Myb would not only generate larger cell numbers through repetitive antigenic stimulations but also preserve a greater abundance of stem cell-like T CM cells. As we previously showed, antigen re-stimulation induced the formation of CD62L − effector cells (Fig. 7a,b) . By contrast, most pmel-1 T cells overexpressing c-Myb retained high CD62L expression throughout multiple stimulations (Fig. 7a,b) . Notably, restimulated T cells preserved their mitochondrial mass only when c-Myb was constitutively overexpressed (Fig. 7c,d ). Even after a multi-log expansion, Myb-overexpressing T cells exhibited significant SRC and fatty acid metabolism ( Fig. 7e-g) , highlighting the importance of c-Myb in the maintenance of metabolic fitness. To evaluate their therapeutic efficacy, we adoptively transferred multiply stimulated, Myb-overexpressing pmel-1 T cells into mice bearing subcutaneous B16-hgp100 melanomas in conjunction with the administration of IL-2. Myb-overexpressing T cells triggered curative responses in all mice, whereas controls cells failed to cure four out of five animals (Fig. 7h) . Conversely, the antitumor efficacy of pmel-1 T cells was severely impaired in the absence of c-Myb (data not shown). To determine whether the transfer of stem celllike T CM cells in the Myb-overexpression group conferred long-lasting antitumor memory responses, we re-challenged the surviving animals with tumors around 200 d after the primary T cell transfer. Remarkably, tumors did not grow in any of the re-challenged animals ( Fig. 7h) , indicating that overexpression of c-Myb enhances the establishment of long-lived immunological memory. Consistent with this observation, we found increased numbers of memory T cells in the surviving mice that received Myb-overexpressing T cells 470 d earlier ( Supplementary Fig. 8a,b ). Although all memory T cells displayed a stem cell-like T CM cell phenotype ( Supplementary  Fig. 8c ), a larger fraction of Myb-overexpressing T cells than control cells was capable of producing IL-2 ( Supplementary Fig. 8d ). Taken together, these findings highlight the therapeutic potential of maneuvers aimed at increasing c-Myb activity in CD8 + T cells.
Discussion
The molecular programs that regulate the formation and maintenance of stem cell-like T cells are not fully resolved. In this current study, we identified c-Myb as a master regulator of CD8 + T cell stemness. In the absence of c-Myb, antigen-stimulated CD8 + T cells are driven toward terminal effector differentiation and are prone to apoptosis, resulting in both qualitative and quantitative impairment of memory responses. These conclusions are further supported by the observation that CD8 + T cells deficient in the microRNA miR-150, a known inhibitor of c-Myb, have an enhanced propensity to form long-lived memory T cells 38 . Our findings run parallel to those in stem cells and progenitor cells, in which c-Myb is seen to restrain differentiation 20,21 , illuminating a conserved molecular program regulating self-renewal and differentiation 5 .
Mechanistically, we demonstrated that c-Myb enhances CD8 + T cell survival and memory development by promoting expression of the gene encoding the anti-apoptotic molecule Bcl2 and by inducing Tcf7, which encodes a transcription factor (Tcf1) essential to the formation and maintenance of stem cell-like T CM cells 13, 14 .
Recently, Tcf1 expression has also been associated with the maintenance of CXCR5 + Tim3 − stem cell-like T cells in chronic infection and cancer [39] [40] [41] [42] . Future work will determine whether c-Myb plays an important role in maintaining this cell population. We further demonstrated that c-Myb also actively repressed pro-differentiating programs by inhibiting the transcription of Zeb2, which encodes a transcription factor identified as a major driver of terminal effector differentiation 31 . This result further emphasizes the understudied repressive function of c-Myb, often considered a transcriptional activator. The repressive activity of c-Myb has been linked to its competitive binding with positive transcription regulators to target gene promoters 43 and to the recruitment of cell type-specific repres-sors 44, 45 . While we have not formally addressed the latter mechanism, complementation studies with Myb pBind unequivocally excluded the possibility of a mechanism of competition with positive transcriptional regulators, as the c-Myb DNA-binding domain failed to suppress Zeb2 transcription or restore physiological numbers of memory precursor cells on its own. Recently, it was proposed that c-Myb-mediated repression might paradoxically involve its interaction with the coactivator p300, possibly through the induction of repressive non-coding RNAs 28 . Consistent with this view, we found that Myb 304GP, which has been shown to have an impaired ability to recruit p300 34, was unable to repress Zeb2 or inhibit terminal effector differentiation.
Our complementation studies also indicate that the C-terminal NRD domain of c-Myb has an important function in regulating CD8 + T cell survival. The mechanistic basis of this finding remains to be elucidated. Myb NRD contains an EVES motif that has been shown to bind p100 46 . Although p100 overexpression inhibited the transcriptional activity of c-Myb in in vitro-cultured fibroblasts 46 , this molecule has been demonstrated to function as a coactivator in other settings 47, possibly indicating its involvement in the prosurvival programs triggered by c-Myb. Finally, our study has profound therapeutic implications for T cell-based immunotherapy. Uncoupling T cell differentiation from T cell expansion has been sought after as the 'holy grail' of adoptive immunotherapy, as the therapeutic efficacy depends considerably on both the cell dose and differentiation status of infused T cells 37, 48 .
Thus far, strategies that have been shown to effectively promote stem cell-like memory T cells have the downside effect of impairing cell expansion 4, 17, 49, 50 . Overexpression of c-Myb not only preserved CD8 + T cell stemness by inhibiting differentiation but also allowed a better cell yield, resulting in curative antitumor responses and the establishment of long-term, tumor-specific immunologic memory. The Myb platform may ultimately pave new avenues for the generation of cell-based immunotherapy on the basis of the adoptive transfer of stem cell-like T CM cells. A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
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Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals C57BL/6NCr and B6-Ly5.1/Cr were from Charles River Frederick Research Model Facility; pmel-1 (B6. Cg-Thy1a/Cy Tg(TcraTcrb)8Rest/J) mice were from the Jackson Laboratory; Cre-ERT2 (B6-Gt(ROSA)26Sortm9(cre/Esr1)Arte) mice were from Taconic. Mybfl/fl mice18 were obtained from Timothy Bender, University of Virginia, Charlottesville, VA and were back-crossed with C57BL/6NCr mice for >30 generations, USA; Zeb2fl/fl mice were kindly obtained from Susan Kaech, Yale University, New Heaven, CT, USA. Pmel-1 mice were crossed with Mybfl/fl mice for the generation of pmel-1 Mybfl/fl mice and were further crossed with Cre-ERT2 mice for the generation of pmel-1 Cre-ERT2 Mybfl/fl mice. pmel-1 Cre-ERT2 Mybfl/fl mice were further crossed with Zeb2fl/fl mice to obtain pmel-1 Cre-ERT2 Mybfl/fl Zeb2wt/fl mice. Spleens from Tcf7GFP/+ mice51 were obtained from Avinash Bhandoola, National Cancer Institute and Hai-Hui Xue, Iowa University. Sex and age (6-10 weeks) matched mice were employed unless otherwise indicated.
Wild animals
No wild animals were used in the study.
Field-collected samples
No field-collected samples were employed in this study.
Ethics oversight
All mouse experiments were done with the approval of the National Cancer Institute Animal Care and Use Committee.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation
Mice spleen and lymph nodes were homogenized using 40uM strainer and syringe. Lungs were homogenized using a gentleMACS™ Dissociator. Naive or whole CD8+ T cells were enriched using enrichment kits from Stem Cell technology.
Instrument
BD FACS Aria II, BD FACS LSRII, BD FACS Fortessa Software BD FACSDivaTM 8.0 was used to acquire the data, Flowjo_v9.9.4 was used to analyze the data Cell population abundance Purity after cell sort was determined by Flow Cytometry. The target population purity was higher than 88% for all experiments.
Gating strategy
All cell populations were analyzed by gating on lymphocytes, singlets, live cells and congenic/reporter markers (Thy1.1, Ly5.1, Ly5.2 or GFP depending on the markers expressed by the adoptively transferred cells).
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
